Lindbrook Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Lindbrook Capital's JNJ Position: Q1 2025 in Review
Lindbrook Capital reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2025, selling an estimated $698K and leaving 28,861 shares worth $4.79M. The position accounts for 0.44% of the portfolio, ranked #33.
Lindbrook Capital first reported a position in JNJ in Q4 2018 and has held it in 26 quarters since. The position peaked at $8.54M in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.
- Lindbrook Capital held 28,861 shares of Johnson & Johnson worth $4.79M as of Q1 2025.
- Lindbrook Capital sold 4,460 Johnson & Johnson shares in Q1 2025, an estimated $698K.
- Johnson & Johnson made up 0.44% of Lindbrook Capital's portfolio in Q1 2025, its #33 holding.
- Lindbrook Capital first reported a position in Johnson & Johnson in Q4 2018 and has held it in 26 quarters since.
- Lindbrook Capital's Johnson & Johnson position peaked at $8.54M in Q4 2022.
- 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.